348 related articles for article (PubMed ID: 20569274)
1. Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes.
Nectoux J; Fichou Y; Rosas-Vargas H; Cagnard N; Bahi-Buisson N; Nusbaum P; Letourneur F; Chelly J; Bienvenu T
J Cell Mol Med; 2010 Jul; 14(7):1962-74. PubMed ID: 20569274
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients.
Delgado IJ; Kim DS; Thatcher KN; LaSalle JM; Van den Veyver IB
BMC Med Genet; 2006 Jul; 7():61. PubMed ID: 16859563
[TBL] [Abstract][Full Text] [Related]
3. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
Braunschweig D; Simcox T; Samaco RC; LaSalle JM
Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
[TBL] [Abstract][Full Text] [Related]
4. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the parental origin of de novo MECP2 mutations and X chromosome inactivation in fifteen sporadic cases with Rett syndrome].
Zhu XW; Pan H; Li MR; Bao XH; Zhang JJ; Wu XR
Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):565-9. PubMed ID: 19951486
[TBL] [Abstract][Full Text] [Related]
6. Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations.
Ravn K; Roende G; Duno M; Fuglsang K; Eiklid KL; Tümer Z; Nielsen JB; Skjeldal OH
Orphanet J Rare Dis; 2011 Aug; 6():58. PubMed ID: 21878110
[TBL] [Abstract][Full Text] [Related]
7. X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome.
Young JI; Zoghbi HY
Am J Hum Genet; 2004 Mar; 74(3):511-20. PubMed ID: 14973779
[TBL] [Abstract][Full Text] [Related]
8. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.
Ballestar E; Ropero S; Alaminos M; Armstrong J; Setien F; Agrelo R; Fraga MF; Herranz M; Avila S; Pineda M; Monros E; Esteller M
Hum Genet; 2005 Jan; 116(1-2):91-104. PubMed ID: 15549394
[TBL] [Abstract][Full Text] [Related]
9. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.
Jordan C; Li HH; Kwan HC; Francke U
BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923
[TBL] [Abstract][Full Text] [Related]
10. Atypical Rett syndrome in a girl with mosaic triple X and MECP2 variant.
Takahashi S; Takeguchi R; Kuroda M; Tanaka R
Mol Genet Genomic Med; 2020 Mar; 8(3):e1122. PubMed ID: 31943886
[TBL] [Abstract][Full Text] [Related]
11. Biotin tagging of MeCP2 in mice reveals contextual insights into the Rett syndrome transcriptome.
Johnson BS; Zhao YT; Fasolino M; Lamonica JM; Kim YJ; Georgakilas G; Wood KH; Bu D; Cui Y; Goffin D; Vahedi G; Kim TH; Zhou Z
Nat Med; 2017 Oct; 23(10):1203-1214. PubMed ID: 28920956
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome.
Delépine C; Nectoux J; Letourneur F; Baud V; Chelly J; Billuart P; Bienvenu T
Neuromolecular Med; 2015 Dec; 17(4):353-63. PubMed ID: 26208914
[TBL] [Abstract][Full Text] [Related]
13. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain.
Balmer D; Arredondo J; Samaco RC; LaSalle JM
Hum Genet; 2002 Jun; 110(6):545-52. PubMed ID: 12107440
[TBL] [Abstract][Full Text] [Related]
14. Rett Syndrome, a Neurodevelopmental Disorder, Whole-Transcriptome, and Mitochondrial Genome Multiomics Analyses Identify Novel Variations and Disease Pathways.
Aldosary M; Al-Bakheet A; Al-Dhalaan H; Almass R; Alsagob M; Al-Younes B; AlQuait L; Mustafa OM; Bulbul M; Rahbeeni Z; Alfadhel M; Chedrawi A; Al-Hassnan Z; AlDosari M; Al-Zaidan H; Al-Muhaizea MA; AlSayed MD; Salih MA; AlShammari M; Faiyaz-Ul-Haque M; Chishti MA; Al-Harazi O; Al-Odaib A; Kaya N; Colak D
OMICS; 2020 Mar; 24(3):160-171. PubMed ID: 32105570
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.
Andoh-Noda T; Akamatsu W; Miyake K; Matsumoto T; Yamaguchi R; Sanosaka T; Okada Y; Kobayashi T; Ohyama M; Nakashima K; Kurosawa H; Kubota T; Okano H
Mol Brain; 2015 May; 8():31. PubMed ID: 26012557
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
[TBL] [Abstract][Full Text] [Related]
17. MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning.
Zahorakova D; Lelkova P; Gregor V; Magner M; Zeman J; Martasek P
J Hum Genet; 2016 Jul; 61(7):617-25. PubMed ID: 26984561
[TBL] [Abstract][Full Text] [Related]
18. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
Wan M; Zhao K; Lee SS; Francke U
Hum Mol Genet; 2001 May; 10(10):1085-92. PubMed ID: 11331619
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological reactivation of inactive X-linked
Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
[TBL] [Abstract][Full Text] [Related]
20. [Genetic features and mechanism of Rett syndrome in Chinese population].
Zhang X; Zhao Y; Bao X; Zhang J; Cao G; Wu X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):1-5. PubMed ID: 24510551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
